The Effect of Age in Patients with Triple Vessel CAD Undergoing PCI vs. Surgery

Original Title: Effects of Age and Sex on Clinical Outcomes after Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients with Triple Vessel Coronary Artery Disease. Reference: KyoheiYamaji et al. Circulation. 2016 Mar 23. [Epub ahead of print].

 

Sex and age are factors that are often considered in the daily practice to decide between PCI or surgery.

The multicenter CREDO-Kyoto trial included 25816 patients; 5651 (men n=3998 and women n=1653) had triple vessel CAD and were considered good candidates for revascularization both with PCI and CABG (PCI n=3,165 and CABG n=2,486).

Patients were divided in three groups according to age tertile: ≤65 years (n=1,972), 66-73 years (n=1,820), and ≥74 years (n=1,859).

There was an excess mortality risk in ≥74 year old patients undergoing PCI compared to those undergoing CABG (HR 1.40, CI 95% 1.10 to 1.79; p=0.006), whereas this risk was neutral for ≤65 year old patients (HR 1.05, CI 95% 0.73 to 1.53; p=0.78) and also neutral for the group between 66 and 73 years of age (HR 1.03, CI 95% 0.78 to 1.36; p=0.85).

The excess mortality risk in the PCI group was significant in men (HR 1.24, CI 95% 1.03 to 1.50; p=0.02) and tended to be significant in women (HR 1.34 IC 95% 0.98 a 1.84; p=0.07).

Conclusion
There was a significant association between age and mortality risk in ≥74 year old patients with triple vessel CAD undergoing PCI compared to those undergoing CABG. The risk was neutral in younger patients.

More articles by this author

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

Coronary angioplasty with drug-eluting stents (DES) is associated with a 2-3% annual incidence of stent-related events, a risk that has not significantly decreased despite...

Is Angioplasty Always Necessary after TAVR?

Courtesy of: Silvina E. Gomez, MD The prevalence of coronary artery disease (CAD) in patients undergoing TAVR is high, ranging from 40 to 70%, according...

Provisional Stenting vs. Two-Stent Technique in Non-Complex Left Main Disease: Three-Year Follow-Up of the EBC-Main Study

In left main coronary artery (LMCA) disease, for lesions of low to intermediate complexity according to the SYNTAX score, percutaneous coronary intervention (PCI) has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...